Short Interest in MediPharm Labs Corp. (OTCMKTS:MEDIF) Expands By 72.1%

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the target of a large growth in short interest in the month of January. As of January 30th, there was short interest totaling 166,605 shares, a growth of 72.1% from the January 15th total of 96,780 shares. Based on an average trading volume of 107,556 shares, the short-interest ratio is presently 1.5 days. Based on an average trading volume of 107,556 shares, the short-interest ratio is presently 1.5 days.

MediPharm Labs Price Performance

MEDIF opened at $0.05 on Friday. The firm has a 50 day moving average price of $0.05 and a 200-day moving average price of $0.05. MediPharm Labs has a twelve month low of $0.04 and a twelve month high of $0.09.

About MediPharm Labs

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.